References
- Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465-75
- Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry 2006;163:1561-8
- Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-18
- Greenberg P, Corey-Lisle PK, Birnbaum HG, et al. Economic implications of treatment-resistant depression among employees. PharmacoEconomics 2004;22:363-73
- Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996;19:179-200
- Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105
- Thase ME, Rush AJ. When at first you don’t succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997;58:23-9
- Souery D, Amsterdam J, de Montigny C, et al. Treatment-resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol 1999;9:83-91
- Corey-Lisle PK, Birnbaum HG, Greenberg PE, et al. Identification of a claims data ‘signature’ and economic consequences for treatment-resistant depression. J Clin Psychiatry 2002;63:717-26
- Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002;63:963-71
- Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003;53:649-59
- Russell JM, Hawkins K, Ozminkowski RJ, et al. The cost consequences of treatment-resistant depression. J Clin Psychiatry 2004;65:341-7
- Berlim MT, Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 2007;52:46-54
- Health Affairs. Press release: number of Americans with job-based health benefits grew through early 2001, despite higher benefit costs. January 8, 2002. Available at: http://www.healthaffairs.org/press/janfeb0202.htm [Last accessed June 17, 2002]
- American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 2nd edn, 2000. Available at http://www.psychiatryonline.com/pracGuide/loadGuidelinePdf.aspx?file=MDD2e_Inactivated_04-16-09 [Last accessed 25 June 2009]
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
- Romano PS, Roos LL, Jollis J. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 1993;46:1075-79
- Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-17
- Gibson TB, Jing Y, Carls GS, et al. The cost burden of treatment resistance in patients with depression. Value Health 2009;12:A177
- Pincus HA, Pettit AR. The societal costs of chronic major depression. J Clin Psychiatry 2001;62(Suppl. 6):5-9